UNIVERSITE CLAUDE BERNARD - LYON 1;INSERM (Institut National de la Santé et de la Recherche Médicale);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.);ENS - Ecole Normale Supérieure de Lyon
发明人:
申请号：
EP20173231.0
公开号：
EP3711762A1
申请日:
2014.09.10
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to methods and pharmaceutical compositions for the treatment of hepatitis B virus infection. In particular, the present invention relates to farnesoid X receptor (FXR) agonists for use in a method for the treatment of hepatitis B virus infection in a subject in need thereof.
